Reagents-qiaseq targeted DNA custom panel (96)-6601-6700

Ended Purchase Order Awarded Last action

Contract number
75N90023P00526
Awardee
Awarding agency
Obligated
$10,140

Award facts

Contract value 100% obligated
$10,139.80 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health Clinical Center awarded Qiagen, LLC a $10,139.80 firm fixed price purchase order for REAGENTS-QIASEQ TARGETED DNA CUSTOM PANEL (96)-6601-6700. Qiagen will provide the requested targeted DNA custom panel reagents to the NIH Clinical Center in Bethesda, Maryland by July 26, 2023. As the prime contractor, Qiagen will self-perform this contract without the use of major subcontractors. The award utilizes a standard firm fixed price contract type to procure specific reagents in support of the NIH Clinical Center's biomedical research efforts.

Quick answers

Who was awarded contract 75N90023P00526?

75N90023P00526 was awarded to Qiagen, LLC by NIH Clinical Center (National Institutes of Health) on June 27, 2023.

How much is contract 75N90023P00526 worth?

The government has obligated $10,140 on 75N90023P00526.

Was contract 75N90023P00526 competed?

The extent of competition for 75N90023P00526 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award